Cargando…
Asialo-rhuEPO as a Potential Neuroprotectant for Ischemic Stroke Treatment
Neuroprotective drugs to protect the brain against cerebral ischemia and reperfusion (I/R) injury are urgently needed. Mammalian cell-produced recombinant human erythropoietin (rhuEPO(M)) has been demonstrated to have excellent neuroprotective functions in preclinical studies, but its neuroprotectiv...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143832/ https://www.ncbi.nlm.nih.gov/pubmed/37111367 http://dx.doi.org/10.3390/ph16040610 |